Silver Spring-based United Therapeutics settles patent dispute over Remodulin generic with Teva Pharmaceuticals - Washington Business Journal
Crowell & Moring Client Alert: NJ Federal Court Says Pharmaceutical Manufacturers Can Agree to Keep Generics Off The Market
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Several blockbuster patents to expire in 2023 - BioStock
The biggest drug patent losses for 2013 - GaBI Journal
PATENT EXPIRY DATES 1/3 | New Drug Approvals
High-Court-Sides-Teva-Patent
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Branded Generics Market Size, Share & Trends Report, 2030
Drug Patent Expirations and the “Patent Cliff”
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Blockbuster immunology drugs facing patent expiry and biosimilar competition - Pharmaceutical Technology
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Can new CEO Erez Vigodman inject life back into Teva? | World Finance
Teva Capitalizes On Patent Expiry To Launch First Perforomist Rival :: Generics Bulletin
US drug expiries: 2020 to be a big year for drug market exclusivity expiries
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Expiry of biologics patents positive for pharma this year, says survey
List - 54 Drug Patents Expiring in 2024 - GreyB
TEVA drug pipeline, global patents
Time for a Turnaround at Teva Pharmaceuticals Industries Ltd? | The Motley Fool
Patent expiry dates for biologicals: 2016 update - GaBI Journal
3 Top Pharmaceuticals: Patents, Pipelines And Prospects | Seeking Alpha
Does Drug Patent Evergreening Prevent Generic Entry? – DrugPatentWatch - Make Better Decisions
Coreg: Glaxo Wins $235 Million Verdict Against Teva Over Patent Infringement - Bloomberg
